הפודקאסטים הטובים ביותר ב-CCO (2024)

1
How to Make Depression Care an Integral Part of HIV Care 50:58

2d ago50:58

50:58

In this episode, Bradley N. Gaynes, MD, MPH, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating depression in people living with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, including creation of a virtual network and employment of measurement-…

1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs 34:45

5d ago34:45

34:45

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…

1
Olympic Parallels for Communicators: A Conversation with Paris 2024 CEO Étienne Thobois 30:25

10d ago30:25

30:25

Earlier this year, Page Up Chair Umayma Abubakar had the opportunity to interview Étienne Thobois, the Paris 2024 CEO, about the upcoming 2024 Paris Olympic and Paralympic Games at our Spring Seminar. For this episode, we bring you their conversation, which covered topics ranging from stakeholder engagement, project management and cross-cultural co…

1
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience 21:53

16d ago21:53

21:53

In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient sel…

1
Current Clinical Practice and NCCN Guidelines for CLL/SLL 31:33

9d ago31:33

31:33

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs 28:35

15d ago28:35

28:35

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…

1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways 24:23

16d ago24:23

24:23

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…

1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer 24:30

18d ago24:30

24:30

In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…

1
Congress to Clinic: Expert Takeaways on Emerging Data for AML 25:21

19d ago25:21

25:21

In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS 19:19

22d ago19:19

19:19

In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…

1
Humanity Creates Value 45:09

24d ago45:09

45:09

In this episode, we explore the findings from IRG’s new research, which Page participated in, and their implications for Chief Communications Officers. We also hear Dana Holmes's practical experience at Blue Cross Blue Shield and Marc de Swaan Arons's insights from the Institute for Real Growth.על ידי Page Society

1
Managing Weight Gain on ART 24:00

1M ago24:00

24:00

In this episode, Cristina Mussini, MD,and William R. Short, MD, MPH, FIDSA,discuss the potential role of ART in weight change among people living with HIV. Listen to their conversation on whether ART switch can lead to weight loss after weight gain and how to counsel people living with HIV on weight loss options, including lifestyle modifications a…

1
Guest episode, The Specifics Matter: Reinforcing Credibility in a Multi-Stakeholder Environment 45:10

1M ago45:10

45:10

Please enjoy this episode of G&S Communications' podcast Building Brand Gravity titled The Specifics Matter: Reinforcing Credibility in a Multi-Stakeholder Environment. It featured a wide-ranging conversation with Page Up members Steve Halsey and Rob Jekielek with our very own Eliot Mizrachi.על ידי Page Society

1
A Triumphant Return: Welcoming People Back to HIV Care 12:33

1M ago12:33

12:33

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, uses a case study to illustrate why patients living with HIV may disengage with their care and how best to reengage them once they present at the clinic, including discussion of: The valid reasons patients have for disengaging with their HIV care Why the return to care should be c…

1
Mpox: Making Vaccination Routine 13:49

1M ago13:49

13:49

In this second podcast of our series, hear expert faculty explore the CDC recommendations for mpox protection and discuss how vaccination can lead to immunologic equity. Topics include: Should we consider mpox an STI? What strategies can be used to improve mpox vaccination and overcome the challenges of vaccine implementation? Can mpox vaccine be c…

1
Mpox Infection and Prevention 19:41

1M ago19:41

19:41

Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including: Why is mpox relevant to clinical practice? Who is at highest risk for mpox? How is mpox transmitted, and what are the clinical manifestations and complications of mpox infections? What are current ACIP recommendations for …

1
How Plain Language Improves Workplace Health and Safety 14:27

2M ago14:27

14:27

When employers commit to using plain language, they make it easier for workers to do their jobs. They also help to support a more inclusive workplace. In this episode, we talk with plain language expert Jocelyn Pletz about how clear and simple communication can improve health and safety. Released: June 5, 2024 File Size: 8.2 MB Length: 14:26 minute…

1
Breaking Down Key PrEP Barriers: Patient and Regimen-Based Factors 11:50

2M ago11:50

11:50

In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include: Individual and community perspectives on PrEP barriers Key barriers by principal populations Strategies to support PrEP delivery PrEP options for ke…

1
Actively Countering Health Disparities to Improve PrEP Uptake 15:09

2M ago15:09

15:09

In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including: Targeting key populations that would benefit from PrEP but have low rates of uptake, such as transgender women and people who inject drugs Addressing intersectionality Overcoming implicit bias Addressing PrEP inequity …

1
Addressing Provider and Structural PrEP Barriers 14:40

2M ago14:40

14:40

In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics covered include: Potential provider barriers to prescribing PrEP Strategies to facilitate conversations about PrEP Addressing the gap in PrEP provider tra…

1
Leveraging the Airwaves 32:44

2M ago32:44

32:44

In this special episode of the New CCO, Jesse Betend, our longtime producer, flips the script on Eliot. Together, they dive deep into the history of the New CCO Podcast, and recount some of the more profound lessons they've learned.על ידי Page Society

1
Proactively Considering if Each Person Is on the Right HIV ART Regimen for Them 21:26

2M ago21:26

21:26

In this episode, Tristan J. Barber, MA, MD, FRCP, and Roger Bedimo, MD, MS, FACP, help you decide whether and how to modify ART in virologically suppressed individuals by critically appraising whether using newer agents may improve their treatment satisfaction. Listen to their conversation about their own approaches to evaluating whether each perso…

1
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer 25:55

2M ago25:55

25:55

In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone receptor–positive/HER2-negative metastatic breast canc…

1
Embracing Neurodiversity in the Workplace 14:18

2M ago14:18

14:18

In this episode, we chat with Dr. Marie-Hélène Pelletier, a psychologist and business leader, about embracing neurodiverse conditions such as attention deficit hyperactivity disorder, dyslexia, and autism spectrum disorder, in the workplace. Released: May 13, 2024 File Size: 6.9 MB Length: 14:17 minutes…

1
Faire place à la neurodiversité au travail 17:05

2M ago17:05

17:05

Dans cet épisode, nous discutons avec Marie-Hélène Pelletier, Ph. D., psychologue et chef des opérations, au sujet d’adaptation à la neurodiversité, comme le trouble d’hyperactivité avec déficit de l’attention, la dyslexie et le trouble du spectre de l’autisme en milieu de travail Date de diffusion : 13 may 2024 Taille du fichier : 8 MB Durée : 17 …

1
HIV Monitoring for People Receiving Long Acting PrEP 5:38

3M ago5:38

5:38

In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the updated CDC guidance on how to monitor for HIV in people receiving PrEP, including: Rationale for why HIV monitoring differs for people receiving LA vs daily PrEP Description of LEVI syndrome How to transition a person from LA PrEP to HIV ART if they test positive for HIV Presente…

1
Studies of LA ART in People With Adherence Challenges or Viremia 9:36

3M ago9:36

9:36

In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the newest data supporting LA ART use in people with adherence challenges or viremia, including: The LATITUDE study, an open-label phase III study of LA CAB + RPV in people with a suboptimal response or nonadherence to oral ART Updates to the Ward 86 cohort, which showed 81% of patien…

1
Simplifying RSV Vaccination: Expert Q&A 9:27

3M ago9:27

9:27

In this episode, Angela Branche, MD, FIDSA, and Jewel Mullen, MD, MPH, MPA, FACP, address commonly asked questions about the RSV vaccine, including: Considerations for vaccine eligibility Recommendations for pregnant persons Vaccine administration based on RSV seasonality Use of the vaccine in persons receiving immunosuppressive medications Safety …

1
Implementing RSV Vaccines Into Practice 11:50

3M ago11:50

11:50

In this episode, Jewel Mullen, MD, MPH, MPA, FACP, discusses strategies for implementing RSV vaccines into practice, with an emphasis on: Understanding the reasoning for Advisory Committee on Immunization Practices RSV vaccine recommendations Factors that influence vaccine uptake and patient decision-making Considerations for patient and healthcare…

1
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 47:23

3M ago47:23

47:23

In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies for applying these recommendations in your clinical practice to optimize treatment and outcomes. The greater discussion addresses: Optimal selection of therapy for treatment-naive CLL, includin…

1
Understanding Risk Factors for Severe RSV Disease 14:06

3M ago14:06

14:06

In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including: RSV seasonality and disease burden Symptoms and complications of RSV infection Older age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization) Comorbidities associated with increased risk of RSV hospita…

1
Optimizing Shingles Vaccine Uptake 47:53

3M ago47:53

47:53

Using common case scenarios, Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss strategies for optimizing shingles vaccine uptake, including: The pathophysiology of shingles to better understand risk and burden CDC guidelines and ACIP shingles vaccine recommendations, including considerations for those who are immunocompromised…

1
Integrating New Data From CROI 2024: Pharmacist Perspectives 27:52

3M ago27:52

27:52

In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, cover the most impactful clinical studies presented at CROI 2024, including: New data on long-acting ART, including: The CARES study of LA CAB + RPV in a sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study ev…

1
How Primary Care Providers Can Expand Their Role in HBV Management 18:52

3M ago18:52

18:52

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care Provide HBV management resources to support PCPs who are doing screening Consider specialty and primary care collaborations that empower PCPs …

1
Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma 12:29

4M ago12:29

12:29

In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examine…

1
Linkage to Care After HBV Diagnosis: Sharing Session 3 16:54

4M ago16:54

16:54

In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma) Applying CDC recommendations …

1
Day of Mourning: Melanie Kowalski-Fleming’s Story 13:21

4M ago13:21

13:21

"Mark was not one to go to the hospital. If he could duct tape or crazy glue it to fix it, he would. This was so much more than what duct tape or crazy glue could fix.” Melanie Kowalski-Fleming’s life changed forever the day her husband fell off a ladder at work. Hear her powerful story. Released: April 8, 2024 File Size: 7.5 MB Length: 13:20 minut…

1
Key HIV Studies From CROI 2024 Influencing Clinical Practice 44:22

4M ago44:22

44:22

In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: New data surrounding long-acting ART, including: The CARES study of LA CAB + RPV in a Sub-Saharan African population using a public health approach The IMPAACT 2017 MOCHA study eva…

1
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer 48:15

4M ago48:15

48:15

In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinations Study design nuances and findings from key randomiz…

1
How to Implement Earlier Hepatitis B Treatment 21:27

4M ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
How to Implement Earlier Hepatitis B Treatment 21:27

4M ago21:27

21:27

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness co…

1
Comprendre les effets de la sensibilité aux parfums 6:47

4M ago6:47

6:47

Pour certains travailleurs, l’eau de Cologne et les crèmes à mains peuvent sentir bon, mais pour leurs collègues qui présentent une sensibilité aux parfums, elles peuvent avoir des effets désagréables pour la santé. En fait, les réactions aux parfums, comme les maux de tête, les démangeaisons oculaires et les difficultés respiratoires, sont un prob…

1
Making Sense of Scent Sensitivities 5:11

4M ago5:11

5:11

While the scent of cologne or hand lotion may be pleasant to some, for co-workers with sensitivities to fragrances, they may have unpleasant health effects. In fact, reactions to scents, such as headaches, itchy eyes, and difficulty breathing, are a medical condition and recognized disability under the Canada Human Rights Act. Released: March 18, 2…

1
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer 36:29

4M ago36:29

36:29

In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the pathologic testing for HER2-low expression Optimal treatmen…

1
The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis 29:38

5M ago29:38

29:38

In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenter…

1
Empowering Patients With Education on HBV: Sharing Session 2 16:49

5M ago16:49

16:49

In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Opportunities to improve patient education, including education for expectant mothers with HBV Potential cultural considerations that may result in delayed HBV diagnosis and care Stigma reduction with…

פודקאסטים ששווה להאזין

פודקאסטים בנושא CCO

פודקאסטים ששווה להאזין

מדריך עזר מהיר